Key result
Anticoagulation is linked to lower mortality in dialysis patients with AF despite increased severe bleeding.
Why the study?
Does anticoagulation therapy reduce all-cause mortality in dialysis patients with atrial fibrillation?
Does anticoagulation therapy reduce all-cause mortality in dialysis patients with atrial fibrillation?
Anticoagulation therapy in dialysis patients with AF is associated with lower all-cause mortality but higher severe bleeding risk, necessitating individualized treatment and careful monitoring.
Answers are grounded in this paper and cite their sources.
Supports individualized anticoagulation decisions in dialysis AF despite bleeding risk; leaves open confirmation of mortality benefit in randomized trials.
: In dialysis patients with AF, anticoagulation therapy is associated with an increased incidence of severe bleeding, but anticoagulation therapy is associated with a low incidence of all-cause mortality. Individualized anticoagulation therapy with careful bleeding monitoring is needed in dialysis patients with AF.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) studied this question. Anticoagulation therapy in dialysis patients with atrial fibrillation is associated with a lower incidence of all-cause mortality despite an increased risk of severe bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: